SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-012193
Filing Date
2024-04-16
Accepted
2024-04-16 16:33:39
Documents
8
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A clnn20230912_def14a.htm DEF 14A 890878
2 clenelogo17percent.jpg GRAPHIC 15272
3 clnn20230112_def14aimg002.jpg GRAPHIC 3362
4 clnn20230112_def14aimg003.jpg GRAPHIC 3654
5 compnetloss25pct.jpg GRAPHIC 35788
6 comptsr25pct.jpg GRAPHIC 37254
7 proxycardback.jpg GRAPHIC 99932
8 proxycardfront.jpg GRAPHIC 128706
  Complete submission text file 0001437749-24-012193.txt   1338916
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39834 | Film No.: 24848233
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)